Literature DB >> 19888193

Obtaining highly purified Toxoplasma gondii oocysts by a discontinuous cesium chloride gradient.

Sarah E Staggs1, Mary Jean See, J P Dubey, Eric N Villegas.   

Abstract

Toxoplasma gondii is an obligate intracellular protozoan pathogen that commonly infects humans. It is a well characterized apicomplexan associated with causing food- and water-borne disease outbreaks. The definitive host is the feline species where sexual replication occurs resulting in the development of the highly infectious and environmentally resistant oocyst. Infection occurs via ingestion of tissue cysts from contaminated meat or oocysts from soil or water. Infection is typically asymptomatic in healthy individuals, but results in a life-long latent infection that can reactivate causing toxoplasmic encephalitis and death if the individual becomes immunocompromised. Meat contaminated with T. gondii cysts have been the primary source of infection in Europe and the United States, but recent changes in animal management and husbandry practices and improved food handling and processing procedures have significantly reduced the prevalence of T. gondii cysts in meat. Nonetheless, seroprevalence in humans remains relatively high suggesting that exposure from oocyst contaminated soil or water is likely. Indeed, waterborne outbreaks of toxoplasmosis have been reported worldwide supporting the theory exposure to the environmental oocyst form poses a significant health risk. To date, research on understanding the prevalence of T. gondii oocysts in the water and environment are limited due to the lack of tools to detect oocysts in the environment. This is primarily due to the lack of efficient purification protocols for obtaining large numbers of highly purified T gondii oocysts from infected cats for research purposes. This study describes the development of a modified CsCl method that easily purifies T. gondii oocysts from feces of infected cats that are suitable for molecular biological and tissue culture manipulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888193      PMCID: PMC3142894          DOI: 10.3791/1420

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


It is important to follow all safety precautions when working with T. gondii oocysts. In most healthy individuals, T. gondii infection is readily controlled by the immune system; however, a life-long infection results. Immunocompromised individuals are particularly susceptible to toxoplasmosis and should not handle T. gondii oocysts. Pregnant women should also not handle T. gondii oocysts, because infection can cause severe birth defects8. T. gondii oocysts should only be handled in a designated area and with trained personnel. Signs indicating T. gondii oocyst work is in progress must be posted to alert others entering the designated area. Wear appropriate personal protective equipment (PPE) such as a lab coat, disposable gown, disposable gloves, and proper eye protection or a face shield when handling T. gondii oocysts. Frequent glove changes are recommended. Do not handle any lab equipment with T. gondii oocyst contaminated gloves. Always use metal autoclavable trays lined with a disposable absorbent liners when working with T. gondii oocysts. Ensure all racks, tubes, etc. used are either disposable or autoclavable. All T. gondii waste must be autoclaved twice for at least one hour. All non-disposable equipment (racks, trays, etc.) must also be autoclaved twice for at least one hour. Vacuum lines used to aspirate liquids should be connected to a Vacushield™ filter to prevent contamination of the vacuum pump. All affected laboratory bench-tops must be disinfected after completing work with T. gondii oocysts. Freshly made 10% hypochlorite should be liberally applied to the work area and allowed dry. The area must then be rinsed well with water. Prepare a 1 L 2.2 M solution of sucrose by dissolving 752.66 g of sucrose in 600 ml ddH2O. Stir and heat gently using a heated stir plate to dissolve the sucrose. Once completely dissolved, bring volume to 1 L with ddH2O. This should be followed by sterilization by autoclaving the solution for at least 20 minutes. Prepare a 1L TE buffer (50 mM Tris-HCl, 10 mM EDTA), pH 7.2 by adding 6.05 g of Tris-HCl and 3.7 g of EDTA in 700 ml of ddH2O, adjust pH to 7.2 then bring volume to 1 L with ddH2O. For the CsCl gradient, prepare a stock solution of CsCl with a specific gravity of 1.15 (1.15-CsCl) by adding 21.75 g of CsCl with 103.25 ml of TE Buffer. For Solution A, mix 30 ml of TE with 20 ml of 1.15-CsCl. For Solution B, mix 20 ml of TE with 30 ml of 1.15-CsCl and 12.5 μl of phenol red solution. For Solution C, mix 10 ml of TE with 40 ml of 1.15-CsCl (Table 1). Prepare a 1L 1 N solution of sodium hydroxide (NaOH) by dissolving 40 g of NaOH, in 800 ml of ddH2O. Once dissolved, bring volume to 1 L with ddH2O. Prepare a 1 L 2% (by volume) solution of H2SO4 mixing 20 ml of H2SO4 with 980 ml of ddH2O. Add 10 ml of a fecal suspension of T. gondii oocysts, in 2% H2SO4, into a 50 ml conical centrifuge tube. It must be noted that fecal suspension refers to samples that have been pre-processed through a sucrose flotation procedure as previously described8. When the fecal samples are initially harvested from the infected cats they are processed through a sucrose float as described in reference 8. This additional sucrose float is necessary to further minimize fecal debris carried over to the CsCl purification process and obtain the purest T. gondii oocysts possible. Neutralize the 2% H2SO4 by adding 6 ml (3/5 volumes) of 1 N NaOH to the fecal suspension. Mix well by vortexing. Add an equal volume (16 ml) of 2.2 M sucrose creating a final concentration of 1.1 M to the fecal suspension and mix well by vortexing. Carefully overlay the sucrose/fecal suspension with 10 ml ddH2O using a 10 ml pipette. Centrifuge the suspension at 1,200 x g for 20 min at room temperature with no brake. Carefully collect the top water and interphase layers and transfer to a new 50 ml conical centrifuge tube by pipetting from the air-water interface without swirling the pipette. It is important to minimize sucrose carryover while collecting the interphase layer. Mix the remaining sucrose/fecal pellet solution by vortexing the tube. Repeat steps 3.4 and 3.5. Bring the volume of the two oocyst interphase solutions to 50 ml with ddH2O and centrifuge the tubes at 2,000 x g for 10 minutes at room temperature. Aspirate the supernatant from each tube and resuspend pellets with 5 ml TE buffer and pool the oocyst suspension together. The total pooled volume should be 10 ml. Prepare a discontinuous CsCl gradient in a 50 ml polycarbonate Oak Ridge tube by carefully underlaying each layer using a 50 ml syringe with an 18 gauge blunt-ended, autoclavable, steel needle, and a 2 way stop cock. Note: Phenol red is added to Solution B to easily distinguish between the gradient layers (Table 1). Slowly add the following solutions to the tube in the order listed below. It should be noted that the flow rate should not exceed more than 0.5 ml/sec. 10 ml of the TE/oocyst suspension sample 8 ml Solution A 8 ml Solution B 8 ml Solution C Centrifuge the Oak Ridge tube at 12,000 x g for 60 min at 4 °C with no brake. Use of a fixed angle rotor is acceptable, but a high speed swinging bucket results in better separation of the oocysts from the suspension sample with minimal fecal debris smears along the side or the tube. The extent of the smears depends on the composition of the fecal suspension and thus it may be necessary to perform two CsCl gradients if the fecal suspension is extremely dirty. Following centrifugation, collect the opaque/white oocyst containing band between solutions A and B. To minimize contamination with fecal debris, go directly to the oocyst band without disturbing the gradient and collect the oocyst interphase using a 10 ml pipette. Transfer the oocyst interphase to a new 50 ml conical centrifuge tube. Try to minimize the amount of CsCl solution aspirated while collecting the oocyst interphase as it may pose a problem in pelleting the oocysts during the wash step. Wash oocysts with 30-40 ml of ddH2O. Centrifuge the tube at 2,000 x g at room temperature for 10 min with no brake. Carefully aspirate the supernatant without disturbing the oocyst pellet. Repeat the wash 2 additional times. At the end of the final wash, carefully aspirate the supernatant and resuspend the pellet in 10 ml 2% sulfuric acid and store at 4 °C until use. Oocysts are now ready for further manipulation. Oocyst purity can be checked microscopically by the absence of fecal debris in the sample.
  6 in total

1.  Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team.

Authors:  W R Bowie; A S King; D H Werker; J L Isaac-Renton; A Bell; S B Eng; S A Marion
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

2.  Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers.

Authors:  J P Dubey; D E Hill; J L Jones; A W Hightower; E Kirkland; J M Roberts; P L Marcet; T Lehmann; M C B Vianna; K Miska; C Sreekumar; O C H Kwok; S K Shen; H R Gamble
Journal:  J Parasitol       Date:  2005-10       Impact factor: 1.276

Review 3.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

Review 4.  How to detect Toxoplasma gondii oocysts in environmental samples?

Authors:  Aurélien Dumètre; Marie Laure Dardé
Journal:  FEMS Microbiol Rev       Date:  2003-12       Impact factor: 16.408

5.  Purification of Toxoplasma gondii oocysts by cesium chloride gradient.

Authors:  Aurélien Dumètre; Marie-Laure Dardé
Journal:  J Microbiol Methods       Date:  2004-03       Impact factor: 2.363

6.  Waterborne toxoplasmosis, Brazil, from field to gene.

Authors:  Lenildo de Moura; Lilian Marcia Garcia Bahia-Oliveira; Marcelo Y Wada; Jeffrey L Jones; Suely H Tuboi; Eduardo H Carmo; Walter Massa Ramalho; Natal J Camargo; Ronaldo Trevisan; Regina M T Graça; Alexandre J da Silva; Iaci Moura; J P Dubey; Denise O Garrett
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

  6 in total
  10 in total

1.  Determining UV inactivation of Toxoplasma gondii oocysts by using cell culture and a mouse bioassay.

Authors:  Michael W Ware; Swinburne A J Augustine; David O Erisman; Mary Jean See; Larry Wymer; Samuel L Hayes; J P Dubey; Eric N Villegas
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

2.  The development and implementation of a method using blue mussels (Mytilus spp.) as biosentinels of Cryptosporidium spp. and Toxoplasma gondii contamination in marine aquatic environments.

Authors:  Sarah E Staggs; Scott P Keely; Michael W Ware; Nancy Schable; Mary Jean See; Dominic Gregorio; Xuan Zou; Chunlei Su; J P Dubey; Eric N Villegas
Journal:  Parasitol Res       Date:  2015-09-11       Impact factor: 2.289

3.  Diagnostic value of a Rec-ELISA using Toxoplasma gondii recombinant SporoSAG, BAG1, and GRA1 proteins in murine models infected orally with tissue cysts and oocysts.

Authors:  Mert Döşkaya; Ayşe Caner; Hüseyin Can; Sultan Gülçe İz; Yaprak Gedik; Aysu Değirmenci Döşkaya; Mina Kalantari-Dehaghi; Yüksel Gürüz
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

4.  Serum Metabolic Profiling of Oocyst-Induced Toxoplasma gondii Acute and Chronic Infections in Mice Using Mass-Spectrometry.

Authors:  Chun-Xue Zhou; Wei Cong; Xiao-Qing Chen; Shen-Yi He; Hany M Elsheikha; Xing-Quan Zhu
Journal:  Front Microbiol       Date:  2018-01-04       Impact factor: 5.640

5.  Proteomic Differences between Developmental Stages of Toxoplasma gondii Revealed by iTRAQ-Based Quantitative Proteomics.

Authors:  Ze-Xiang Wang; Chun-Xue Zhou; Hany M Elsheikha; Shuai He; Dong-Hui Zhou; Xing-Quan Zhu
Journal:  Front Microbiol       Date:  2017-06-02       Impact factor: 5.640

6.  Discovery of new Toxoplasma gondii antigenic proteins using a high throughput protein microarray approach screening sera of murine model infected orally with oocysts and tissue cysts.

Authors:  Mert Döşkaya; Li Liang; Aarti Jain; Hüseyin Can; Sultan Gülçe İz; Philip Louis Felgner; Aysu Değirmenci Döşkaya; David Huw Davies; Adnan Yüksel Gürüz
Journal:  Parasit Vectors       Date:  2018-07-04       Impact factor: 3.876

7.  Differential Brain MicroRNA Expression Profiles After Acute and Chronic Infection of Mice With Toxoplasma gondii Oocysts.

Authors:  Rui-Si Hu; Jun-Jun He; Hany M Elsheikha; Fu-Kai Zhang; Yang Zou; Guang-Hui Zhao; Wei Cong; Xing-Quan Zhu
Journal:  Front Microbiol       Date:  2018-10-02       Impact factor: 5.640

8.  Comparative Phosphoproteomic Analysis of Sporulated Oocysts and Tachyzoites of Toxoplasma gondii Reveals Stage-Specific Patterns.

Authors:  Ze-Xiang Wang; Liang Che; Rui-Si Hu; Xiao-Lin Sun
Journal:  Molecules       Date:  2022-02-02       Impact factor: 4.411

9.  Isospora suis in an epithelial cell culture system - an in vitro model for sexual development in coccidia.

Authors:  Hanna Lucia Worliczek; Bärbel Ruttkowski; Lukas Schwarz; Kirsti Witter; Waltraud Tschulenk; Anja Joachim
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

10.  Transcriptomic Profiling of Mouse Brain During Acute and Chronic Infections by Toxoplasma gondii Oocysts.

Authors:  Rui-Si Hu; Jun-Jun He; Hany M Elsheikha; Yang Zou; Muhammad Ehsan; Qiao-Ni Ma; Xing-Quan Zhu; Wei Cong
Journal:  Front Microbiol       Date:  2020-10-19       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.